Swander Pace Capital has agreed to sell its over-the-counter products portfolio company, Insight Pharmaceuticals, to Prestige Brands for $750 million. “It has been a pleasure working with CEO Gary Downing, the Insight team and our co-invest partner, Ontario Teachers’ Pension Plan, to grow Insight into one of the leading OTC pharmaceutical companies,” said Mo Stout, […]
October 7, 2026
Private equity's news leader since 2007
Chicago, Illinois
"There is a right and a wrong in the universe, and that distinction is not hard to make."
Superman